News
Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...
“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...
Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...
The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...
In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...
Explore more
A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...
An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...
Adults over 50 and those with chronic conditions are at risk too. Learn how to protect yourself and where to go for more information.
Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results